Ignite Creation Date:
2025-12-25 @ 4:01 AM
Ignite Modification Date:
2026-04-24 @ 7:20 AM
Study NCT ID:
NCT00809302
Status:
TERMINATED
Last Update Posted:
2009-08-28
First Post:
2008-12-15
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Efficacy and Safety Study of Aplindore in Patients With Early Parkinson Disease
Sponsor:
Neurogen Corporation
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
Aplindore-211
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
None
Responsible Party Affiliation:
Old Name:
Ken Sprenger, MD, MBBCh, Vice President, Clinical Development and Operations
Old Organization:
Neurogen Corporation